NPPA fixes retail price of Certain Hard Gelatin Capsules; Check Details

New Delhi: Through a recent notice, the drug price regulator National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of hard gelatin capsules.

The formulation manufactured by Jubilant contains Alpha Lipoic Acid USP 100mg, Methylcobalamin 1500mcg, Vitamin B6 IP 3mg, Folic Acid IP 1.5mg, Benfotiamine 50mg, Biotin USP 5mg, Chromium Picolinate USP eq. to Chromium 200mcg. While the formulation manufactured by KonTest includes Alpha Lipoic Acid USP 200mg, Methylcobalamin 1500mcg, Vitamin B6 IP 3mg, Folic Acid IP 1.5mg, Benfotiamine 50mg, Biotin USP 5mg.

The cost of each capsule has been fixed at around Rs 11.

The notification reads;

The notice further adds;

• The manufacturer of above-mentioned formulations i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table


• The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said


• The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and


• As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the


• The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing


• In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act,


• Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s)

Also Read: NPPA fixes the retail price of Emcure pharma’s HIV drug